Your browser doesn't support javascript.
loading
The recombinome of IKZF1 deletions in B-cell precursor ALL.
Lopes, Bruno A; Meyer, Claus; Bouzada, Heloysa; Külp, Marius; Maciel, Ana Luiza Tardem; Larghero, Patrizia; Barbosa, Thayana C; Poubel, Caroline P; Barbieri, Caroline; Venn, Nicola C; Pozza, Luciano Dalla; Barbaric, Draga; Palmi, Chiara; Fazio, Grazia; Saitta, Claudia; Aguiar, Thais F; Lins, Mecneide M; Ikoma-Colturato, Maura R V; Schramm, Marcia; Chapchap, Eduardo; Cazzaniga, Gianni; Sutton, Rosemary; Marschalek, Rolf; Emerenciano, Mariana.
Afiliação
  • Lopes BA; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil. blopes@inca.gov.br.
  • Meyer C; DCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany. blopes@inca.gov.br.
  • Bouzada H; DCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany.
  • Külp M; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.
  • Maciel ALT; DCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany.
  • Larghero P; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.
  • Barbosa TC; DCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany.
  • Poubel CP; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.
  • Barbieri C; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.
  • Venn NC; Program of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.
  • Pozza LD; Molecular Diagnostics, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, NSW, Australia.
  • Barbaric D; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Palmi C; Sydney Children's Hospital, Randwick, NSW, Australia.
  • Fazio G; Tettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Saitta C; Tettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Aguiar TF; Tettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Lins MM; Arthur Siqueira Cavalcanti Hematology Institute (HEMORIO), Rio de Janeiro, Brazil.
  • Ikoma-Colturato MRV; Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil.
  • Schramm M; Hospital Amaral Carvalho, São Paulo, Brazil.
  • Chapchap E; Prontobaby Hospital da Criança, Rio de Janeiro, Brazil.
  • Cazzaniga G; Serviço de Hematologia, Hospital do Câncer I, INCA, Rio de Janeiro, Brazil.
  • Sutton R; Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Marschalek R; Tettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Emerenciano M; Medical Genetics, School of Medicine and Surgery, University of Milan Bicocca, Monza, Italy.
Leukemia ; 37(8): 1727-1731, 2023 08.
Article em En | MEDLINE | ID: mdl-37386080

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Leucemia-Linfoma Linfoblástico de Células Precursoras B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Leucemia-Linfoma Linfoblástico de Células Precursoras B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article